Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema
ICD-10 E09.349 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema.
E09.349 refers to diabetes mellitus that is induced by drugs or chemicals, characterized by severe nonproliferative diabetic retinopathy without macular edema. This condition arises when certain medications or substances lead to insulin resistance or impaired insulin secretion, resulting in elevated blood glucose levels. Patients may present with symptoms typical of diabetes, including polyuria, polydipsia, and unexplained weight loss. The severe nonproliferative diabetic retinopathy indicates significant retinal changes, such as microaneurysms and retinal hemorrhages, but without the presence of macular edema, which is a more severe complication. Management of this condition involves controlling blood glucose levels, often through insulin therapy, and monitoring for diabetic complications, particularly ocular issues. Regular eye examinations are crucial to assess the progression of retinopathy and to implement timely interventions.
Detailed medication history, HbA1c levels, and retinopathy assessment.
Patients presenting with new-onset diabetes due to medication, requiring insulin management.
Ensure accurate documentation of the drug responsible for diabetes and its management.
Comprehensive eye examination findings, including retinal imaging.
Patients with diabetes presenting for routine eye exams showing signs of retinopathy.
Document the absence of macular edema clearly to avoid misclassification.
Used for follow-up visits for diabetes management.
Document patient's diabetes management plan and retinopathy assessment.
Endocrinologists should ensure comprehensive documentation of diabetes control.
Medications such as corticosteroids, certain antipsychotics, and some chemotherapy agents are known to induce diabetes mellitus by affecting insulin sensitivity or secretion.
